Cargando…
Late Reaction to Ustekinumab Infusion
Psoriasis is a chronic inflammatory disease that directly affects the quality of life. Biologics are prescribed for patients unresponsive to conventional treatments and with severe forms of the disease. Ustekinumab is a fully human monoclonal antibody against the p40 subunit of interleukins 12/23 th...
Autores principales: | Morais, Marina Resener, Meneghello, Luana Pizarro, de Oliveira, Carina Flores, Carvalho, André Vicente Esteves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209708/ https://www.ncbi.nlm.nih.gov/pubmed/25386321 http://dx.doi.org/10.4081/dr.2013.e2 |
Ejemplares similares
-
The use of ustekinumab in a patient with severe psoriasis and
positive HBV serology()
por: Steglich, Raquel Bissacotti, et al.
Publicado: (2014) -
Case series: psoriasis in solid organ transplant patients and immunobiological agents()
por: Meneghello, Luana Pizarro, et al.
Publicado: (2023) -
Interstitial Granulomatous Drug Reaction to Ustekinumab
por: Walker, A., et al.
Publicado: (2022) -
Translation and validation of the Simplified Psoriasis Index (SPI)
into Brazilian Portuguese
por: de Morais, Marina Resener, et al.
Publicado: (2018) -
Do you know this syndrome?()
por: Frainer, Renata Hubner, et al.
Publicado: (2013)